Navigation Links
U-M to develop guide for parents of children with disorders of sex development
Date:1/16/2013

Ann Arbor, Mich. When a child is born with a disorder of sex development, decisions regarding gender assignment and genital surgery are often made quickly and under pressure.

Quite often those decisions are surgical and often irreversible. Former patients and health care advocates have long complained that parents are provided inadequate information to make decisions for their child with a disorder of sex development.

But with a new award from the Patient-Centered Outcomes Research Institute (PCORI), researchers at the University of Michigan hope to provide parents with the tools needed to make decisions about disorders of sex development (DSD).

"When a child with a disorder of sex development is born, parents are often experiencing enormous distress," says David E. Sandberg, Ph.D., director of the Division of Child Behavioral Health at C.S. Mott Children's Hospital and professor of pediatrics and communicable diseases at the University of Michigan Medical School.

"The right decisions about gender assignment -- is it a boy or a girl -- and the best course of action (for example should there be surgery? what kind? when?) are not obvious."

"Parents can make decisions that they think are in the best interest of the child that they will regret later."

DSD is a term that describes a wide range of diagnoses that affect the development of sex organs, whether due to chromosomes, hormones, or other factors.

Sandberg said despite significant progress, genetic diagnosis does not necessarily offer clear guidance for parents about gender assignment or best treatment. "It can open the door to additional uncertainties," he says.

Sandberg's project, which has a proposed budget of about $1.3 million, would create a decision-making aid that could be used in genetic counseling and test-result disclosure that would prepare parents to be fully involved in management or treatment plans for their children.

"We want to support parents becoming actively involved in making those decisions, and reduce the likelihood of future worry and regret about decisions that have been made," he says, adding that the guide will educate families about sex development of the body, how disorders are diagnosed (especially how to interpret genetic test results), and possible relationships between diagnostic/genetic testing, decisions about care, and known consequences of those decisions on their child and entire family.

Sandberg plans to introduce the decision-making guide into care for persons affected by DSD and evaluate its effectiveness through an existing network of medical centers supported by the National Institute of Child Health and Human Development. The DSD Translational Research Network is comprised of health care providers and researchers at the University of Michigan/C.S. Mott Children's Hospital, UCLA, UCSF, Seattle Children's Hospital and other medical centers.

PCORI funded the project as part of an effort to help patients make better-informed health decisions.

"Today marks a major milestone in our work as we build a portfolio of comparative clinical effectiveness research that will provide patients and those who care for them better information about the health care decisions they face," said PCORI Executive Director Joe Selby, MD, MPH. "These research projects reflect PCORI's patient-centered research agenda, emphasizing the inclusion of patients and caregivers at all stages of the research."

PCORI is committing $40.7 million in funding for a slate of 25 projects, which were approved by PCORI's Board of Governors following a competitive, multi-stage review process involving scientists, patients, caregivers and other stakeholders. Proposals were evaluated on the basis of scientific merit, engagement of patients and stakeholders, methodological rigor and fit within PCORI's National Priorities for Research and Research Agenda.

The awards were part of PCORI's first cycle of primary research funding and selected from among nearly 500 completed applications submitted earlier this year. All proposals were approved pending a business and programmatic review by PCORI staff and completion of a formal award contract.


'/>"/>

Contact: Mary F. Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Developed new method to diagnose hereditary breast and ovarian cancer
2. Development of the first way to make large amounts of promising anti-cancer substance
3. Embracing debate on how cancers develop: Without the answer, effective therapies remain elusive
4. U of T and Harvard study finds growing weight extremes in the developing world
5. ASH international clinical collaboration replicates high cure rate of APL in developing countries
6. Protein identified that can disrupt embryonic brain development and neuron migration
7. Cervical cancer screening in less-developed areas should be tailored to local conditions
8. EPC Group Appoints Industry Veteran to Lead Development Practice Expansion
9. Medical Service Bureau (MSB) takes Next Step in Growth Initiative, Hires Director of Business Development
10. US Drug Watchdog Now Urges Family Members Mourning The Loss Of A Loved One Who Developed Bladder Cancer After Using The Diabetes Drug Actos To Call The Johnson Law Group
11. Postpartum depression prevalent in under-developed countries, could impact baby health and mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider of ... for those suffering from the full spectrum of disordered eating, announced today that the ... from nearly all 50 states and several countries converged on the Green Valley Resort ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... Ramin Assili, announce that they are now offering treatments for sleep apnea and ... at dental offices. Sleep apnea , specifically the obstructive type, is increasingly ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... the year of enhancements, upgrading their training and leads programs. , In February, ... Reserved for elite sales agents, Performance Partners is designed to teach how to ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... of inspiring stories about real people of God in congregations across the United ... Miller, a Presbyterian minister ordained in 1964 who has served congregations in seven ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... to their communities, 16 more public health departments have been awarded national accreditation ... another 4.5 million people into the expanding network of communities across the nation ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 24, 2017  GenomeDx Biosciences today announced that six ... Decipher® Prostate Cancer Classifier tests will be presented at ... (EAU) Congress held March 24 to 28, 2017 in ... Congress is Europe,s largest urological ... the urological field. The abstract titled "Muscle ...
(Date:3/24/2017)... BOTHELL, Wash. , March 23, 2017 /PRNewswire/ ... developer of advanced medical technology for non-invasive surgery, ... the Mirabilis System for treatment of uterine fibroids ... that it had received approval from the US ... study of the Mirabilis System in the United ...
(Date:3/24/2017)... Mar 24, 2017 The Board of Directors ... Annual Report 2016 including the complete 2016 Annual Accounts with ... on Nordic Nanovector,s website in the section Investor Relations/Reports and ... ... Tone Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
Breaking Medicine Technology: